These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 4378429)

  • 41. Cellular mechanisms involved in the release of slow reacting substance of anaphylaxis.
    Orange RP; Stechschulte DJ; Austen KF
    Fed Proc; 1969; 28(5):1710-5. PubMed ID: 4185891
    [No Abstract]   [Full Text] [Related]  

  • 42. SRS-A and other mediators. Slow reacting substance biosynthesis, characterization and purification.
    Yecies LD; Parker CW
    Monogr Allergy; 1979; 14():155-62. PubMed ID: 41174
    [No Abstract]   [Full Text] [Related]  

  • 43. Purification and some physicochemical properties of slow-reacting substance of anaphylaxis (SRS-A) from sensitized guinea pig lung.
    Watanabe S; Koda A
    Microbiol Immunol; 1979; 23(10):1009-22. PubMed ID: 42007
    [No Abstract]   [Full Text] [Related]  

  • 44. Slow-reacting substance of anaphylaxis (SRS-A) from lung tissue.
    Piper PJ; Tippins JR; Samhoun MN; Morris HR; Taylor GW; Jones CM; Sculley N; Rokach J; Girard Y
    Kroc Found Ser; 1981; 14():13-21. PubMed ID: 6947070
    [No Abstract]   [Full Text] [Related]  

  • 45. Effects of Ca2+ antagonist, nicardipine, on experimental asthma with special reference to slow reacting substance of anaphylaxis.
    Koshino T; Fujimura M; Nishioka S; Okafuji K; Minami S; Kanamori K; Matsuda T; Ishizaki T; Saga T; Miyabo S
    Allergy; 1985 Jul; 40(5):311-3. PubMed ID: 4037252
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antianaphylactic agents. 1. 2-(Acylamino)oxazoles.
    Ross WJ; Harrison RG; Jolley MR; Neville MC; Todd A; Verge JP; Dawson W; Sweatman WJ
    J Med Chem; 1979 Apr; 22(4):412-7. PubMed ID: 430478
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunochemical and biologic properties of rat IgE. 3. Modulation of the IgE-mediated release of slow-reacting substance of anaphylaxis by agents influencing the level of cyclic 3',5'-adenosine monoposphate.
    Kooman WJ; Orange RP; Austen KF
    J Immunol; 1970 Nov; 105(5):1096-102. PubMed ID: 4395186
    [No Abstract]   [Full Text] [Related]  

  • 48. The partial purification of slow reacting substance of anaphylaxis from rat peritneal anaphylactic fluid and its separation from an arachidonic acid releasing substance.
    Whelan CJ
    Biochem Pharmacol; 1980 Feb; 29(3):319-23. PubMed ID: 7362644
    [No Abstract]   [Full Text] [Related]  

  • 49. Mediators of the anaphylactic reaction.
    Vane JR
    Ciba Found Study Group; 1971; 38():121-31. PubMed ID: 4116295
    [No Abstract]   [Full Text] [Related]  

  • 50. Modulation of the release of SRS-A from bovine lung in vitro by several autonomic and autacoid agents.
    Burka JF; Eyre P
    Int Arch Allergy Appl Immunol; 1976; 50(6):664-73. PubMed ID: 1270160
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An eosinophil leukocyte chemotactic factor of anaphylaxis.
    Kay AB; Stechschulte DJ; Austen KF
    J Exp Med; 1971 Mar; 133(3):602-19. PubMed ID: 4106805
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Release of slow-reacting substance from anaphylactic lung tissue and its modification by beta-sympathomimetics.
    Forsberg K; Sörenby L
    Int Arch Allergy Appl Immunol; 1979; 58(4):430-5. PubMed ID: 437910
    [TBL] [Abstract][Full Text] [Related]  

  • 53. IgE-mediated release of leukotriene C4, chondroitin sulfate E proteoglycan, beta-hexosaminidase, and histamine from cultured bone marrow-derived mouse mast cells.
    Razin E; Mencia-Huerta JM; Stevens RL; Lewis RA; Liu FT; Corey E; Austen KF
    J Exp Med; 1983 Jan; 157(1):189-201. PubMed ID: 6184439
    [TBL] [Abstract][Full Text] [Related]  

  • 54. IgE immune complexes induce immediate and prolonged release of leukotriene C4 (LTC4) from rat alveolar macrophages.
    Rankin JA; Hitchcock M; Merrill WW; Huang SS; Brashler JR; Bach MK; Askenase PW
    J Immunol; 1984 Apr; 132(4):1993-9. PubMed ID: 6421931
    [TBL] [Abstract][Full Text] [Related]  

  • 55. SRS-A and its formation by the lung.
    Piper PJ; Tippins JR; Samhoun MN; Morris HR; Taylor GW; Jones CM
    Bull Eur Physiopathol Respir; 1981; 17(4):571-83. PubMed ID: 7326495
    [No Abstract]   [Full Text] [Related]  

  • 56. In vivo anti-allergic and bronchopulmonary pharmacology of REV 3164 in rats and guinea-pigs.
    Leibowitz M; Gordon RJ; Wolf PS; Sonnino-Goldman P
    Arch Int Pharmacodyn Ther; 1984 Sep; 271(1):135-54. PubMed ID: 6497506
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Release of histamine and slow reacting substance of anaphylaxis (SRS-A) from the sensitized guinea-pig lungs. 1. Experimental studies].
    Kitamura S; Ishihara Y; Shimizu T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1976 Nov; 14(11):645-9. PubMed ID: 64634
    [No Abstract]   [Full Text] [Related]  

  • 58. Improved methodology for evaluating release of mediators of anaphylaxis from guinea pig lung.
    Fleisch JH; Spaethe SM
    Monogr Allergy; 1979; 14():185-8. PubMed ID: 91947
    [No Abstract]   [Full Text] [Related]  

  • 59. Effect of inhibitors of prostaglandin synthesis and prostaglandins E2 and F2alpha on the immunologic release of mediators of inflammation from actively sensitized guinea-pig lung.
    Hitchcock M
    J Pharmacol Exp Ther; 1978 Nov; 207(2):630-40. PubMed ID: 712645
    [TBL] [Abstract][Full Text] [Related]  

  • 60. On the preparation of highly purified slow reacting substance of anaphylaxis (SRS-A) from biological extracts.
    Blackwell GJ; Burka JF; Flower RJ; Torkington P
    Br J Pharmacol; 1980 Jan; 68(1):33-46. PubMed ID: 7357200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.